Women’s experience interacting with the patent medicine vendor (PMV) by type of service received from PMV
| Experience | Abortion (n=193) | Post-abortion care (n=67) | Total (n=260) | P value |
| n (%) | n (%) | n (%) | ||
| Counselled on different treatment options | 159 (82.4) | 48 (71.6) | 207 (79.6) | 0.06 |
| Asked about questions or concerns | 182 (94.3) | 52 (77.6) | 234 (90) | <0.001 |
| Given sufficient information about care | 191 (99) | 67 (100) | 258 (99.2) | 1 |
| Given pain medication | 181 (93.8) | 64 (95.5) | 245 (94.2) | 0.766 |
| Type of pain medication received | 0.055 | |||
| Oral NSAID | 144 (79.6) | 60 (93.8) | 204 (83.3) | |
| Oral paracetamol | 8 (4.4) | 1 (1.6) | 9 (3.7) | |
| Intramuscular injection | 18 (9.9) | 3 (4.7) | 21 (8.6) | |
| Other | 11 (6.1) | 0 (0) | 11 (4.5) | |
| Informed about follow-up care | 187 (96.9) | 67 (100) | 254 (97.7) | 0.343 |
| Informed about when additional care required | 179 (92.7) | 67 (100) | 246 (94.60 | 0.024 |
| Informed about risk of pregnancy post-abortion | 185 (95.5) | 66 (98.5) | 251 (96.5) | 0.454 |
| Felt services were private | 188 (97.4) | 67 (100) | 255 (98.1) | 0.332 |
| Services well explained | 193 (100) | 67 (100) | 260 (100) | – |
| Allowed to express concerns | 192 (95.5) | 65 (97) | 257 (98.8) | 0.172 |
| PMV was welcoming | 193 (100) | 67 (100) | 260 (100) | – |
| Treated in non-judgmental way | 188 (97.4) | 67 (100) | 255 (98.1) | 0.413 |
| Mean cost of service (Nigerian Naira) among clients who paid for service (SD) (range) | 2113 (1590) (1–15,000) | 1348 (642) (1450–3000) | 1967 (1487) (1–15,000) | 0.002 |
| No payment | 11 (5.7) | 24 (35.8) | 35 (13.5) | |
| Perceived affordability of service among clients who paid for service | 0.149 | |||
| Affordable | 156 85.7 | 33 (76.7) | 189 (84) | |
| Cost too much | 26 (14.3) | 10 (23.3) | 36 (16) | |
| Reside in same community as PMV shop | 145 (75.1) | 56 (83.6) | 201 (77.3) | 0.155 |
| Counselled on contraception | 186 (96.4) | 64 (95.5) | 250 (96.2) | 0.721 |
| Methods counselled on* | ||||
| Condoms | 139 (72) | 52 (77.6) | 191 (73.5) | 0.372 |
| Pills | 152 (78.8) | 54 (80.6) | 206 (79.2) | 0.749 |
| DMPA | 159 (82.4) | 57 (85.1) | 216 (83.1) | 0.613 |
| IUCD | 151 (78.2) | 55 (82.1) | 206 (79.2) | 0.503 |
| Implant | 154 (79.8) | 51 (76.1) | 205 (78.8) | 0.526 |
| Female sterilisation | 35 (18.1) | 26 (38.8) | 61 (23.5) | 0.001 |
| Periodic abstinence/withdrawl | 47 (24.4) | 28 (41.8) | 75 (28.8) | 0.007 |
| Felt coerced to accept a method | 14 (13.3) | 8 (21.1) | 22 (15.4) | 0.258 |
| Received a contraceptive method | 105 (54.4) | 38 (56.7) | 143 (55.6) | 0.743 |
| Method received | ||||
| Condoms | 18 (17.1) | 6 (15.8) | 24 (16.8) | |
| Pills | 18 (17.1) | 11 (28.9) | 29 (20.3) | |
| Injection/Depo-Provera | 45 (42.9) | 11 (28.9) | 56 (39.2) | |
| IUCD | 8 (7.6) | 3 (7.9) | 11 (7.7) | |
| Implant | 15 (14.3) | 7 (18.4) | 22 (15.4) | |
| Learnt about new contraceptive method from PMV† | 107 (55.4) | 48 (71.6) | 155 (59.6) | 0.02 |
| Would return to PMV for future services | 192 (99.5) | 67 (100) | 259 (99.6) | 0.555 |
| Would recommend PMV to family or friends | 193 (100) | 67 (100) | 260 (100) | |
| Degree of satisfaction | ||||
| Very satisfied | 166 (86) | 47 (70.1) | 213 (81.9) | 0.005 |
| Mostly satisfied | 25 (13) | 20 (29.9) | 45 (17.3) | |
| Somewhat satisfied | 2 (1) | 0 (0) | 2 (0.8) | |
| Not at all satisfied | 0 (0) | 0 (0) | 0 (0) |
*Multiple response question.
†A new method refers to any modern contraceptive method previously unknown to the client.
DMPA, depot medroxyprogesterone acetate; IUCD, intrauterine contraceptive device; NSAID, non-steroidal anti-inflammatory drug; PMV, patent medicine vendor.